Cervarix HPV Vaccine

Cervarix is the HPV vaccine developed to target the prevent of cervical cancer caused by the human papillomavirus (HPV), types 16 and 18. An adjuvant, AS04, is added to Cervarix to help the high level and long-lasting presence of antibodies against HPV.

The Cervarix HPV Vaccine is recommended for girls as young as 10 years of age. Ideally, the vaccine should be administered before the onset of sexual activity. However, females who are already sexaully active may also benefit from vaccination.

The Cervarix HPV Vaccine was licenced in October 2009 by the U.S. Food and Drug Administration for its use. It has also been tested in many countries around the world. The vaccine was found to be safe and caused no serious side effects.

You should discuss individual concerns with your doctor before receiving the vaccination.

The Cervarix HPV Vaccine should be delivered through a series of three injections over a six-month period. The second dose is given 1 months after the first dose, and the third dose is given 6 months after the first dose.

There is currently no extensive research to compare the effectiveness of Cervarix against Gardasil for the protection of cervical cancer. Studies show that the antibodies level may be higher in women who received the Cervarix vaccine. On the other hand, in addition to cervical cancer, Gardasil is also shown to be effective in preventing vaginal cancer, vulvar cancer, and genital warts.

In general, both HPV vaccines are effective in protection against around 70% of cervical cancers in young women.

You should discuss individual concerns with your doctor before receiving the vaccination.

Cervarix HPV Vaccine HK$1,400 each injection
Promotional Price HK$3,200 (3 injections)

More about : HPV Vaccine

More about : Gardasil and Gardasil 9

More about : Cervical Cancer

More about : Pap Smear Cervical Cancer Screening

HPV Vaccine Information, Centres for Disease Control and Prevention (CDC)

HPV and Vaccine, World Health Organization (WHO)

Cervical Screening Program, Department of Health

Statistics on Cervical Cancer, Centre for Health Protection

Cervical Cancer Prevention, World Health Organization (WHO)